- Report
- October 2024
- 187 Pages
Global
From €3371EUR$3,545USD£2,834GBP
€3745EUR$3,939USD£3,149GBP
- Report
- March 2025
- 50 Pages
Global
From €2520EUR$2,650USD£2,119GBP
Cinitapride is a gastrointestinal drug used to treat gastrointestinal motility disorders. It is a prokinetic agent, meaning it increases the movement of the gastrointestinal tract. It is used to treat symptoms such as abdominal pain, bloating, and constipation. Cinitapride is available in both oral and injectable forms. It is typically used in combination with other medications to treat gastrointestinal disorders.
The cinitapride market is a growing segment of the gastrointestinal drugs market. It is used to treat a variety of gastrointestinal disorders, including irritable bowel syndrome, gastroesophageal reflux disease, and functional dyspepsia. It is also used to treat symptoms associated with delayed gastric emptying.
Some companies in the cinitapride market include AstraZeneca, Merck, Pfizer, and Sanofi. These companies produce both oral and injectable forms of the drug. Show Less Read more